DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 August 31
Nicotinamide Mononucleotide Market Size, Share, Trends and Forecast 2026-2035
Nicotinamide mononucleotide market reached US$ 392.57 million in 2025 and is projected to reach US$ 955.75 million by 2035, growing at a 10.75% CAGR during 2026-2035.
Starting from
$4350$2999
Published: 2026 August 26
Global Regenerative Medicine Market Size, Industry Analysis and Outlook 2026-2033
The global regenerative medicine market reached US$ 61.67 billion in 2025 and is expected to reach US$ 653.42 billion by 2033
Starting from
$4350$2999
Published: 2026 August 26
Allergen Blocker Market Size, Share, Industry, Forecast and outlook (2026-2033)
Allergen Blocker market reached US$ 171.01 million in 2025 and is expected to reach US$ 227.49 million by 2033, growing at a CAGR of 3.64%
Starting from
$4350$2999
Published: 2026 August 23
Nanobody Drug Conjugate Market Outlook 2035: Bispecific Oncology Platforms and Precision Payload Delivery
The nanobody drug conjugate market will grow from US$0.31 billion in 2025 to US$2.18 billion by 2035 at a 21.5% CAGR, led by bispecific oncology NDCs.
Starting from
$4350$2999
Published: 2026 August 19
Refractory Multiple Myeloma Market Size, Share, Industry, Forecast and outlook (2026-2033)
Refractory Multiple Myeloma Market to grow from USD 2.75B in 2025 to USD 4.08B by 2033 at 4.7% CAGR, driven by novel oncology therapies and rising cases.
Starting from
$4350$2999
Published: 2026 August 17
Dystrophin Gene Therapy Market Size, Share Analysis, Growth Trends and Forecast 2026-2033
Dystrophin Gene Therapy Market reached US$ 2.30 Billion in 2025 and is expected to reach US$ 12.00 Billion by 2033, growing at a CAGR of 20.6%
Starting from
$4350$2999
Published: 2026 August 17
US CAR-T Cell Therapy Market Size, Share, Trends and Forecast 2026 to 2035
The U.S. CAR-T Cell Therapy market was valued at US$ 3.85 billion in 2025 and is projected to reach US$ 12.72 billion by 2035, expanding at a CAGR of 12.70% during the forecast period.
Starting from
$3175$2189
Published: 2026 August 17
Clinical Trials Market Size, Share Analysis, Growth Trends and Forecast 2026-2035
The Global Clinical Trials Market reached US$ 76.22 Billion in 2025 and is expected to reach US$ 155.64 Billion by 2035, growing at a CAGR of 7.4% during the forecast period (2026–2035).
Starting from
$4350$2999
Published: 2026 August 15
Next-Generation Obesity Drugs Market Size, Share, Trends and Forecast 2026-2035
Next-generation obesity drugs market reached US$23.13 billion in 2025 and is projected to reach US$121.01 billion by 2035, driven by oral GLP-1s, multi-agonists and amylin therapies.
Starting from
$4350$2999
Published: 2026 August 11
Primary Sclerosing Cholangitis Market Size, Share, Growth, Forecast and Outlook (2026-2033)
Global Primary Sclerosing Cholangitis (PSC) market reached US$ 385.67 million in 2025 and is expected to reach US$ 987.26 million by 2033
Starting from
$4350$2999